Location History:
- Sacramento, CA (US) (2022)
- Davis, CA (US) (2020 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Yoko Takada: Innovator in Myeloid Differentiation and Cellular Signaling
Introduction
Yoko Takada is a prominent inventor based in Sacramento, CA. She has made significant contributions to the field of cellular signaling and inflammation through her innovative research. With a total of 3 patents, her work focuses on understanding and modulating critical biological processes.
Latest Patents
One of her latest patents involves Myeloid differentiation factor 2 (MD2) signaling and modulation. This invention highlights the specific interaction between MD2 and integrin, particularly integrin αvβ3, which plays a crucial role in cellular signaling related to inflammatory responses, including sepsis. The invention proposes a novel method for inhibiting integrin signaling by utilizing an inhibitor of MD2-integrin binding, such as a dominant negative mutant of MD2 that lacks integrin-binding capability. Additionally, it describes methods for identifying inhibitors of MD2-integrin binding, along with polypeptides, nucleic acids, host cells, and corresponding compositions aimed at inhibiting MD2-integrin signaling.
Another significant patent by Yoko Takada focuses on dominant-negative FGF2 antagonists. This invention provides dominant negative mutants of FGF2 that are designed to suppress FGF-mediated cellular signaling. The patent includes related compositions, methods, and kits that can be utilized in various applications.
Career Highlights
Yoko Takada is affiliated with the University of California, where she continues her research and innovation in the field of cellular biology. Her work has garnered attention for its potential applications in medical science and therapeutic development.
Collaborations
Yoko has collaborated with notable colleagues, including Yoshikazu Takada and Seiji Mori, contributing to a rich environment of research and innovation.
Conclusion
Yoko Takada's contributions to the field of cellular signaling and her innovative patents demonstrate her commitment to advancing scientific knowledge. Her work not only enhances our understanding of critical biological processes but also opens new avenues for therapeutic interventions.